EP3601277
Lyfjasamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.3.2018EP published:
11.10.2023EP application number:
18715593.2
EP translation filed:
18.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
27.3.2038Expiry date:
27.3.2027Next due date:
31.3.2027
Title in English:
PHARMACEUTICAL FORMULATIONLanguage of the patent:
English
Timeline
Today
28.3.2018EP application
11.10.2023EP Publication
18.12.2023Translation submitted
15.1.2024Registration published
27.3.2027Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
GEISSLER, SimonAddress:
61352 Bad Homburg, DE
Name:
JESCHKE, MartinaAddress:
64846 Gross-Zimmern, DE
Name:
BONIFORTE, PatriziaAddress:
64665 Alsbach-Haehnlein, DE
Name:
WEIGANDT, MarkusAddress:
68259 Mannheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17163830Date:
30.3.2017Country:
EP
Classification
Categories:
C07D 413/14, A61K 9/14, A61K 9/20, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 14.2.2024
Expires: 27.3.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 14.2.2025
Expires: 27.3.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 20.3.2026
Expires: 27.3.2027
Payer: Árnason Faktor ehf.